The role STAT5 plays in erythroid and megakaryocyte development comes into play when assessing the side effects of suppressing STAT5 through various JAK inhibitor therapies now used for hematopoietic and autoimmune disorders. The gene discussed is STAT5A; the disease is Autoimmunity.